Plasmid-mediated colistin resistance in a patient infected with Klebsiella pneumoniae

Lancet Infect Dis. 2016 Sep;16(9):998-999. doi: 10.1016/S1473-3099(16)30197-9.

Authors

Stefan Nicolet¹, Daniel Goldenberger², Torsten Schwede¹, Malcolm Page³, Marc Creus⁴

Affiliations

¹ Swiss Institute of Bioinformatics and University of Basel, Basel 4056, Switzerland.
² Department of Clinical Microbiology, University Hospital Basel, Basel, Switzerland.
³ Jacobs University, Bremen, Germany.
⁴ Swiss Institute of Bioinformatics and University of Basel, Basel 4056, Switzerland. Electronic address: marc.creus@unibas.ch.

PMID: 27684336
DOI: 10.1016/S1473-3099(16)30197-9

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Colistin / pharmacology*
Colistin / therapeutic use
Drug Resistance, Bacterial / genetics*
Humans
Klebsiella Infections / drug therapy*
Klebsiella Infections / microbiology
Klebsiella pneumoniae / drug effects*
Klebsiella pneumoniae / genetics
Microbial Sensitivity Tests
Plasmids / genetics

Substances

Anti-Bacterial Agents
Colistin